Research Report on Global and China Human Vaccine Industry, 2013-2017

Publisher Name :
Date: 01-Aug-2013
No. of pages: 50

The research object of the report is human vaccines. According to different types and sources, vaccines can be divided into pathogenic protein vaccine, recombinant protein vaccines, immune protein vaccines and gene vaccines.

In China, vaccines are generally divided into Vaccine I and Vaccine II. Vaccine I is offered for free, and it's priced and purchased uniformly by the government, covering the major epidemic diseases of Hepatitis B, epidemic cerebrospinal meningitis, Tetanus, etc. Vaccine II is other vaccines inoculated voluntarily at residents' own expense. It is independently priced and has large profit margins, but there are intense competition in the market. The frequently-used Vaccine II includes Pneumonia vaccine, Varicella Vaccine, Type B Haemophilus Influenzae Conjugate Vaccine, Influenza Vaccine, Rabies Vaccine and so on. In China, Vaccine I market are occupied by state-owned enterprises, while foreign-funded enterprises and private enterprises have certain advantages in Vaccine II market.

In 2012, the scale of Chinese vaccine market was about CNY 19 billion, while the scale of pharmaceutical industry was about CNY 1.78 trillion in the same period. The sales revenue of Chinese vaccine industry was only about 1% of that of the pharmaceutical industry far below the global average level of 3%, estimated by CRI. There is still much space for growth. China has the largest population in the world with 10 million newborns yearly. Meanwhile, the aging of the society is increasingly serious. With the economic development and increasingly frequent population immigrations, it inevitably widens the spreading range and increases the speed of disease spreading. Accordingly, new epidemic diseases (Avian Influenza, Influenza A H1N1 and so on) occur frequently.

Data from China's Ministry of Health shows, in 2012, China reported 3,216,900 cases of Class A and B infectious diseases, with16,721 dead. The reported incidence of Class A, B infectious diseases is 238.76/0.1million and the death rate is 1.24/0.1million. In 2012, China reported 3,734,500 cases of Class C infectious diseases, with 594 dead. The reported incidence of Class C infectious diseases is 277.18/0.1million and the death rate is 0.04/0.1 million. China's infectious disease incidence reflects a growing trend comparing with that in previous years, which gradually prompts government's attention on prevention and control of infectious diseases and planned immunization coverage is expanding; public awareness of vaccination is also increasing continuously which promotes the growth of vaccine market.

In China, there are over 30 human vaccine manufacturing enterprises with annual production of over 1 billion including about 40 kinds of vaccines against more than 20 kinds of viruses. With years of technological accumulation, some private vaccine enterprises make big breakthrough in the technical fields and Vaccine II market.

The great potential demand of China's human vaccine market attract many leading enterprises of international vaccine industry to speed up the layout in China. In 2008, Sanofi Pasteur invested USD 94 million to build vaccine factories in Shenzhen. In 2009, Novartis bought 85% of shares of Zhejiang Tianhua Co., Ltd. at the cost of USD 125 million which was approved in March 2011. In May 2011, GSK ended the cooperation with Watson Biological Company; in June it bought 51% shares of Haiwang Yingtelong Biotechnology Co., Ltd. at the cost of GBP 24 million and established wholly-owned subsidiary company. In September 2011, GlaxoSmithKline signed contracts with Sinopharm, Shanghai Zuellig Pharmaceutical Co., Ltd. and Beijing Keyuan Pharmaceutical Co., Ltd. The three distributors are responsible for the business of North China, Central China and South China respectively and provide services for customers through the cold chain logistics system covering all over the country.

CRI forecasts that China vaccine market will maintain a rapid growth in the future years, but the competition will be fiercer. Some less competitive enterprises will go bankrupt or be merged and reorganized, and the concentration rate of vaccine market will rise continually.

Due to the low vaccination rate in China, there's much space for future growth. With the increase of China's income per capita, residents' health awareness and their ability to pay, the vaccine market will get more opportunities and shares.

More following information can be acquired through this report:


  • Vaccine Industry of China and the World

  • Government Policies on China Vaccine Industry

  • Competition in China Vaccine Market

  • Major Segmentation of China Vaccine Market

  • Development Trend of China Vaccine Market


Following people are recommended to buy this report:

  • Vaccine Manufacturers

  • Vaccine Distributors

  • Research Institutions and Investors Focusing on Vaccine Industry

Research Report on Global and China Human Vaccine Industry, 2013-2017

Table of Contents

Chapter 1 Basic Concept of Human Vaccine Industry
1.1 Definition
1.2 Development Course of Vaccines
1.3 Classification of Vaccines
1.4 Necessity of Vaccination

Chapter 2 Analysis on Global Vaccine Market, 2008-2012
2.1 Scale and Structure of Global Vaccine Market
2.1.1 Scale of Global Vaccine Market
2.1.2 Major Application Groups of Vaccines
2.1.3 Structure of Global Vaccine Market
2.2 Vaccines for Children
2.2.1 Major Varieties
2.2.2 Market Scale of Vaccines for Children
2.3 Vaccines for Adults
2.3.1 Varieties of Vaccines for Adults
2.3.2 Market Scale of Vaccines for Adults

Chapter 3 Development Environment of China Vaccine Industry, 2012-2013
3.1 Economic Environment
3.2 Policy Environment
3.2.1 History of China's Immunization Program
3.2.2 Procedure of Immunization Program
3.3 Relevant Legislation and Criterion of China Vaccine Industry
3.3.1 Research and Registration Stage
3.3.2 Production Stage
3.2.3 Circulation Stage
3.3.4 Supporting Policies of Chinese Government on Vaccine Industry

Chapter 4 Analysis on China's Human Vaccine Market, 2008-2012
4.1 Classification of Vaccines in China
4.2 Scale of China Vaccine Market
4.2.1 Overview
4.2.2 Structure of China Vaccine Market
4.3 Segmentation of China Vaccine Market
4.3.1 Vaccine I Market
4.3.2 Vaccine II Market
4.4 Analysis on Major Vaccines in China
4.4.1 Bacillus Calmette-Guerin
4.4.2 Poliomyelitis Vaccine
4.4.3 Measles-Mump-Rubella Vaccine
4.4.4 Diphtheria and Tetanus (DTP or DTaP) Vaccine
4.4.5 Encephalitis Vaccine
4.4.6 Meningococcus Vaccine
4.4.7 Human Rabies Vaccine
4.4.8 Type B Haemophilus Influenzae Conjugate Vaccine
4.4.9 Influenza Vaccine
4.4.10 Varicella Vaccine
4.4.11 Hepatitis A Vaccine
4.4.12 Pneumococcus Vaccine
4.4.13 Hepatitis B Vaccine

Chapter 5 China's Major Vaccine Manufacturers
5.1 China National Biotec Group (CNBG)
5.1.1 Overview
5.1.2 Subordinate Biological Products Institutions
5.2 Hualan Biological Engineering Co., Ltd.
5.3 Beijing Tiantan Biological Products Co., Ltd.
5.4 Changchun High-Tech Industry (Group) Co., Ltd.
5.5 Haiwang Yingtelong Biotechnology Co., Ltd.
5.6 Other Enterprises

Chapter 6 Prediction on Development of China Vaccine Industry
6.1 Prediction on Supply and Demand
6.1.1 Prediction on Production
6.1.2 Prediction on Market Scale
6.2 Prediction on Development Trend
6.2.1 Technology Trend
6.2.2 Market Trend
6.2.3 Competition Trend

List of Charts

Chart Introduction on Basic Ingredients of Vaccines
Chart Classification of Human Vaccines
Chart Comparison Between Traditional and New Vaccines
Chart Scale of Global Vaccine Market, 2004-2012
Chart Introduction on Major Vaccines in the World
Chart Major Varieties of Pneumonia Vaccines in the World
Chart Major Hepatitis Vaccines in Global Market
Chart World's Major Infectious Diseases Since the 21st century
Chart Market Scale of China Vaccine Industry, 2005-2012
Chart Lot Release Quantity of BCG Vaccine in China, 2010-2012
Chart Market Scale of MMR Vaccine in China, 2010-2012
Chart Lot Release Quantity of Human Rabies Vaccine in China, 2010-2012
Chart Lot Release Quantity of Influenza Vaccine in China, 2010-2012
Chart Prediction on Market Scale of China Vaccine Industry, 2013-2017
Chart Immunization Program Procedure for Chinese Children
Chart Circulation of Vaccines in China
Chart Prediction of China Vaccine Market Scale, 2013-2017

  • China Commercial Vehicle Industry
    Commercial vehicle are usually large trucks, buses or vans used to transport people,  goods and material. China is one of the nations that contributes to over 50% of commercial vehicle production. The industry has grown in leaps and bounds over the couple of years. Even though the growth rates aren’t as impressive as two years [...]
  • The Prospective Market of Drug Eluting Stents
    Drug Eluting Stents are the recent development that’s are now being used frequently for curing narrowed coronary arteries. These stents help to keep the artery open and supply drugs at regular intervals preventing any further obstruction. The stents are usually small scaffolds of wire and are placed in the artery. This has been a welcome [...]
  • Anaesthesia Machine Industry is Flourishing due to an Extensive Customer Base with Therapeutic Needs
    The Anaesthesia Machine Industry comprises of the manufacturers and users of Anaesthesia Machines which are basically workstations or units that assist a person to administer Anaesthesia on the other. It includes plug & play Anaesthesia delivery units (ADUs). The industry also comprises of the various accessories like monitors and information systems and support services involved [...]
  • The Need for an Electric Cars Boosts The Lithium Sulfate Market
    Lithium is a highly demanded material. The popularity of this metal is primarily due to the characteristics of this metal and its compounds. Some of the characteristics of this material are that it has the highest electrochemical potential of all metals, a very high co-efficient of thermal expansion, acting as a viscosity modifier in melts, [...]
  • Tire Roller Industry
    Tire roller is one of the most popular equipment used in the construction industry. A tire roller offers multiple services from building highways, industrial sites, binder courses, wear courses and many more. Tire rollers come with different features like easy adjustment of tyres, flexible ballast, oscillating tires, etc. that facilitates in doing a particular work. [...]
    • The Oil Drilling Rig Industry
    • The Oil Drilling Rig Industry is characterized with a few typical work specific to this industry only. The work begins with the search for new oil basins or construction of wells. During this time the services of drilling contractors and se…

    • HER2-Negative Breast Cancer’s Therapeutic Market
    • HER2-Negative Breast Cancer is the most common form of cancer occurring in women. The long term survival of patients diagnosed with HER2-Negative Breast Cancer depends solely on its early detection as till now there is no medicine that can …

    • The Market of Plate Heat Exchanger
    • Plate heat exchanger is not only very useful but its also easy to maintain, its compact design makes it more efficient, the product is highly cost-efficient and also the materials of this product are easily available. There are some limitat…

    • The Industry of Binding Machines
    • Binding of books and papers is one of the most important aspect of buying and selling books and thus the demand of binding machines. There are different kinds of binding machines available in the market. The binding type determines the bind…

    • The Boom In Women Infertility Market
    • Infertility is an abnormality in the regular functioning of the human reproductive system. Anyone of male or female might be suffering from this issue. Infertility in woman is caused by either a genetical factor or factors such as aging or …

  • Manufacturing of Solid Dosage Forms - Transformation in Manufacturing Concepts and Expanding Contract Manufacturers' Production Capacity May Force Regulatory Bodies to Re-Design Guidelines on Quality Standards
    Published: 10-Feb-2011        Price: US 3500 Onwards        Pages: 83
    GBI Research's report, "Manufacturing of Solid Dosage Forms - Transformation in Manufacturing Concepts and Expanding Contract Manufacturers' Production Capacity May Force Regulatory Bodies to Re-Design Guidelines on Quality Standards" Production Capacity May Force Regulatory Bodies to Re-Design Guidelines on Quality Standards". The report provides the key market data on the Contract Manufacturing Organization (CMO) market size for solid dosage forms along with forecast from 2009-2016 for API and......
  • Travel Vaccines Market to 2017 - Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market
    Published: 11-Apr-2011        Price: US 3500 Onwards        Pages: 105
    GBI Research, the leading business intelligence provider, has released its latest research, "Travel Vaccines Market to 2017 - Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market", which provides insights into the global travel vaccines market and market forecasts until 2017. The report provides an in-depth analysis of the top seven therapeutic indications for which travel vaccines are often prescribed, which includes hepatitis A, ......
  • Accelerating Drugs to Market - In Search of Opportunity Along the Drug Development & Approval Pathway
    Published: 15-Sep-2011        Price: US 3900 Onwards        Pages: 52
    Accelerating Drugs to Market - In Search of Opportunity Along the Drug Development & Approval Pathway Summary The commercial life of a drug and the sales trajectory achieved are dependent on a multitude of factors. One critical factor in achieving success is the ability to bring a product to market quickly to gain competitive advantages and to start recouping development costs. From product concept to market, there are a number of potential areas of opportunity for ......
  • Evolution in the Pain Therapy Drugs Market: Nociceptive and Neuropathic Drug Development
    Published: 05-Jan-2012        Price: US 2265 Onwards        Pages: 126
    Pain Therapy Drugs Market : As the market evolves over the next decade current market leaders will lose patent expiry and become subject to generic competition. What’s in the pipeline and which companies and products will prosper? Pain affects around 1.5 billion people worldwide. In most cases, pain is temporary and easily treated with commonly available analgesics. For some people, however, pain is a debilitating, chronic condition. In Europe, an estimated 20% of the popula......
  • Vaccine Production (Trends, Techniques, Key Players, Spending Estimates and Forecasts)
    Published: 01-Feb-2012        Price: US 2500 Onwards        Pages: 180
    The considerable revenue growth in the vaccine market over the past ten years suggests the amount of vaccine production and the techniques of vaccine production will need to adapt to match a revived industry. This report, Vaccine Production (Trends, Techniques, Key Players, Spending Estimates and Forecasts) examines the market for vaccine manufacturing and production technologies. The focus is on current production methods and ......
  • Pediatric Vaccines Market to 2017- Strategic Focus on Partnering as Licensing and Co-Development Accounted for 69% of Deal-Making Activity from 2004-2011
    Published: 15-Feb-2012        Price: US 3500 Onwards        Pages: 127
    GBI Research, the leading business intelligence provider, has released its latest research, “Pediatric Vaccines Market to 2017- Strategic Focus on Partnering as Licensing and Co-Development Accounted for 69% of Deal-Making Activity from 2004-2011”, which provides insights into global pediatric vaccines market forecast until 2017. The report provides an in-depth analysis of six vaccines which include hepatitis A, hepatitis B, polio, rotavirus, Mumps, Measles and Rubella (MMR) and Diphtheria, Teta......
  • Research Report on Chinese Human Vaccine Industry, 2012
    Published: 07-Mar-2012        Price: US 3000 Onwards        Pages: 50
    The research object of the report is human vaccine apart from animal vaccine. Vaccination is the most economical, effective, safe and convenient way to prevent disease and the investment of vaccination is far more less than that of the treatment. Hence, it is of significance to make great contribution to save social resources. In China, vaccine is customarily divided into vaccine I and Vaccine II. Vaccine I is offered for free, and it's priced and purchased uniformly by government, covering t......
  • Regulatory Intelligence on Biologics Recalls - Immunoglobulins and Vaccines are Involved in More Recalls than Other Drug Classes
    Published: 14-Mar-2012        Price: US 3500 Onwards        Pages: 72
    This report provides in-depth analysis of biologics recalls issued or reported with the US Food and Drug Administration (FDA) and its constituent agencies. The report analyzes biologics recalls on the basis of the reason for recall, therapy area, drug class, dosage forms and the recalling company, on a year-to-year basis from 2007-2010. The report is built on data and information sourced from the FDA database of biologics recalls and in-house analysis by GBI Research's team of industry experts. ......
  • Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies
    Published: 01-Apr-2012        Price: US 3500 Onwards        Pages: 72
    GBI Research's report Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies finds that the global herpes market is an attractive one, and is expected to witness growth during the forecast period and to provide good opportunities for investors. The expected high growth is attributed to increasing awareness regarding herpes infections and a growth in the diseased population. Many promising therapies, especially for Cytomegalovi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs